Back to Agenda
Session 6, Track 3: Ready, Set, Launch: Driving Toward Success Through MSL Contributions
Session Chair(s)
J. Lynn Bass
Director, Medical Science Liaisons, Bristol Myers Squibb, United States
Launch success is shaped long before approval, and the way companies develop their Medical Science Liaisons (MSLs) plays a central role. In this session, attendees will hear three different approaches that companies have used to develop their MSLs for a potential future launch, including how each approaches building scientific expertise, generating actionable insights, and preparing teams to map key stakeholders. Panelists will share the challenges they encountered, the practical solutions they applied, and real-world examples. Participants will leave with best practices, common pitfalls to avoid, and a checklist they can use to shape their own MSL development efforts.
Learning Objective :
At the conclusion of this session, participants should be able to:
- Describe three different approaches companies have used to develop their MSLs ahead of a launch
- Compare the strengths and limitations of each approach to MSL development
- Select elements from these approaches to build an MSL development action plan for launch success
Speaker(s)
Making Launch Readiness Actionable: A Structured Field Medical Model Supported by Generative AI
Eunhye Lee, MPharm
Manager, Global Medical Affairs, Amgen Korea, Korea, Republic of
Have an account?